Hester Biosciences Ltd

Hester Biosciences Limited will hold a board meeting on Thursday, November 5, 2026, to consider the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026, as per SEBI regulations.

Hester Biosciences Limited informed the Bombay Stock Exchange and National Stock Exchange of India that it received a confirmation certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended September 30, 2026, detailing securities dematerialised and rematerialised as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Hester Biosciences Limited announced that its board of directors approved a capital contribution of up to Rs 10.50 million for a 26% stake in SLYCE AGRI WORLD LLP, a limited liability partnership incorporated on November 23, 2016, that generates renewable energy. The investment, to be made in one or more tranches, will facilitate a Power Purchase Agreement and enable Hester Biosciences to become a sole captive member consumer of the generating entity, fulfilling captive compliance requirements. SLYCE AGRI WORLD LLP, based in Ahmedabad, reported a turnover of Rs 1.30 million in fiscal year 2022-23, Rs 40.86 million in fiscal year 2023-24, and Rs 22.40 million in fiscal year 2024-25.

Hester Biosciences Limited informed the Bombay Stock Exchange and National Stock Exchange of India that the trading window for dealing in equity shares of the company will be closed from October 1, 2026, and will remain so until 48 hours after the financial results for the quarter and six months ended September 30, 2026, become publicly available.

Hester Biosciences Ltd announced upgrades to its credit ratings from multiple agencies, reflecting information regarding an upgrade in credit rating. CARE Ratings upgraded Long-term Bank Facilities, Long-term / Short-term Bank Facilities, and Short-term Bank Facilities, with ratings of BBB; Stable, BBB+; Stable, BBB; Stable/ A3 +, BBB+; Stable/ A2, and A3 + and A2 respectively, while also upgrading Long Term Bank Facilities from CARE BBB; Stable to CARE BBB+; Stable with a reduced sanctioned amount from 66.25 to 48.45, and Long Term / Short Term Bank Facilities from CARE BBB; Stable / CARE A3+ to CARE BBB+; Stable / CARE A2, alongside upgrading Short Term Bank Facilities from CARE A3+ to CARE A2; CARE Ratings Ltd. also noted a review with the status of "ISSUER NOT COOPERATING" for certain Bank Facilities, and indicated potential annual surveillance/review, along with monitoring of bank facilities, while CareEdge Ratings indicated that ratings reflect opinions as on the date of the rating, and N/A agencies provided no rating data.

Net profit of Hester Biosciences rose 489.90% to Rs 96.98 crore in the quarter ended June 2026 as against Rs 16.44 crore during the previous quarter ended June 2025. Sales declined 8.17% to Rs 77.24 crore in the quarter ended June 2026 as against Rs 84.11 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales77.2484.11 -8 OPM %29.4927.12 - PBDT23.3824.37 -4 PBT16.3320.19 -19 NP96.9816.44 490 Powered by Capital Market - Live

Hester Biosciences reported standalone revenue of Rs 634.90 million for the quarter ended June 30, 2026, a 14% increase compared to Rs 524.69 million in the corresponding quarter of the previous year, while standalone profit increased by 88%. Consolidated revenue decreased to Rs 772.44 million compared to Rs 841.05 million in the prior year, but consolidated profit rose significantly by 459% due to an exceptional gain of Rs 853.49 million from an amendment to a Gates Foundation loan for Hester Africa, which reduced the outstanding loan from USD 12.0 million to USD 5.0 million.

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 30 July 2026.

Shardul Securities Ltd, BF Utilities Ltd, BCL Industries Ltd and Indian Hume Pipe Company Ltd are among the other gainers in the BSE's 'B' group today, 13 July 2026.Hester Biosciences Ltd surged 20.00% to Rs 2531.25 at 13-Jul-2026 EOD IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 21183 shares were traded on the counter so far as against the average daily volumes of 859 shares in the past one month. Shardul Securities Ltd spiked 19.99% to Rs 40.46. The stock was the second biggest gainer in 'B' group. On the BSE, 15773 shares were traded on the counter so far as against the average daily volumes of 1713 shares in the past one month. BF Utilities Ltd soared 14.98% to Rs 665. The stock was the third biggest gainer in 'B' group. On the BSE, 1.44 lakh shares were traded on the counter so far as against the average daily volumes of 6264 shares in the past one month. BCL Industries Ltd advanced 13.77% to Rs 38.84. The stock was the fourth biggest gainer in 'B' group. On the BSE, 8.87 lakh shares were traded on the counter so far as against the average daily volumes of 86623 shares in the past one month. Indian Hume Pipe Company Ltd added 12.20% to Rs 412.05. The stock was the fifth biggest gainer in 'B' group. On the BSE, 1.01 lakh shares were traded on the counter so far as against the average daily volumes of 12574 shares in the past one month. Powered by Capital Market - Live

Hester Biosciences announced that the 39th Annual General Meeting(AGM) of the company will be held on 21 July 2026.